DROSPIRENONE 3 mg ETHINYLESTRADIOL 0.02 mg - risultati della ricerca

mepha pharma ag - ethinylestradiolum, cyproteroni acetas - confetti - ethinylestradiolum 35 µg, cyproteroni acetas 2 mg, lactosum monohydricum 41.19 mg, cellulosum microcristallinum, povidonum k 30, carmellosum natricum conexum corresp. natrium 0.016 mm, magnesii stearas, Überzug: hypromellosum, e 171, macrogolum 400, e 132, e 172 (flavum), e 172 (nigrum), e 172 (rubrum), e 104, lacca, cera alba, cera carnauba, saccharum 10.36 mg, pro compresso obducto. - androgenisierungserscheinungen - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

diane-35 confetti

bayer (schweiz) ag - ethinylestradiolum, cyproteroni acetas - confetti - ethinylestradiolum 35 µg, cyproteroni acetas 2 mg, lactosum monohydricum 31.115 mg, maydis amylum, povidonum k 25, talcum, magnesii stearas, Überzug: saccharum 19.371 mg, povidonum k 90, macrogolum 6000, calcii carbonas, talcum, glycerolum (85 per centum), cera montana, e 171, e 172 (flavum), pro compresso. - androgenisierungserscheinungen - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

feminac 35 confetti

spirig healthcare ag - ethinylestradiolum, cyproteroni acetas - confetti - ethinylestradiolum 35 µg, cyproteroni acetas 2 mg, colore.: di e 104, e 132, excipiens pro compresso haze. - androgenisierungserscheinungen - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

minerva confetti

berlis ag - ethinylestradiolum, cyproteroni acetas - confetti - ethinylestradiolum 35 µg, cyproteroni acetas 2 mg, lactosum monohydricum 31.115 mg, maydis amylum, povidonum k 25, talcum, magnesii stearas, Überzug: saccharum 19.371 mg, povidonum k 90, macrogolum 6000, calcii carbonas, talcum, glycerolum (85 per centum), cera montana, e 171, e 172 (flavum), pro compresso. - androgenisierungserscheinungen - synthetika